N-3 polyunsaturated fatty acids and inflammation in obesity: Local effect and systemic benefit

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Wang, Yue ^a   Huang, Feiruo ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; G PROTEIN COUPLED RECEPTOR 120; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PHOSPHOLIPID; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; FAT INTAKE;

ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; FAT INTAKE; FATTY ACID ANALYSIS; HUMAN; INFLAMMATION; INTRACELLULAR SIGNALING; LOCAL THERAPY; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PREVENTION STUDY; REGULATORY MECHANISM; REVIEW; SYSTEMIC THERAPY; TREATMENT RESPONSE; DIET THERAPY; METABOLISM; PATHOLOGY;

ADIPOSE TISSUE; DIETARY FATS; FATTY ACIDS, OMEGA-3; HUMANS; INFLAMMATION; OBESITY;

EID: 84939482671     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/581469     Document Type: Review

References (152)

1. H. Xu, G. T. Barnes, Q. Yang et al. , "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance, "The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1821-1830, 2003.
2. K. E. Wellen and G. S. Hotamisligil, "Obesity-induced inflammatory changes in adipose tissue, " The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1785-1788, 2003.
3. M. Mraz and M. Haluzik, "The role of adipose tissue immune cells in obesity and low-grade inflammation, " Journal of Endocrinology, vol. 222, no. 3, pp. R113-R127, 2014.
4. E. D. Rosen and B. M. Spiegelman, "What we talk about when we talk about fat, " Cell, vol. 156, no. 1-2, pp. 20-44, 2014.
5. C. N. Lumeng and A. R. Saltiel, "Inflammatory links between obesity and metabolic disease, "The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2111-2117, 2011.
6. P. C. Calder, "n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases, " The American Journal of Clinical Nutrition, vol. 83, no. 6, supplement, pp. 1505S-1519S, 2006.
7. A. P. Simopoulos, "Omega-3 fatty acids in inflammation and autoimmune diseases, " The Journal of the American College of Nutrition, vol. 21, no. 6, pp. 495-505, 2002.
8. Z. P. Zhan, F. R. Huang, J. Luo, J. J. Dai, X. H. Yan, and J. Peng, "Duration of feeding linseed diet influences expression of inflammation-related genes and growth performance of growing-finishing barrows, " Journal of Animal Science, vol. 87, no. 2, pp. 603-611, 2009.
9. K. Kang, S. M. Reilly, V. Karabacak et al. , "Adipocyte-derived Th2 cytokines and myeloid PPARδ regulate macrophage polarizatioNandinsulin sensitivity, " CellMetabolism, vol. 7, no. 6, pp. 485-495, 2008.
10. G. S. Hotamisligil, P. Arner, J. F. Caro, R. L. Atkinson, and B. M. Spiegelman, "Increased adipose tissue expression of tumor necrosis factor-κin human obesity and insulin resistance, " The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2409-2415, 1995.
11. K. E. Wellen and G. S. Hotamisligil, "Inflammation, stress, and diabetes, "The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111-1119, 2005.
12. J.-P. Bastard, M. Maachi, C. Lagathu et al. , "Recent advances in the relationship between obesity, inflammation, and insulin resistance, " European Cytokine Network, vol. 17, no. 1, pp. 4-12, 2006.
13. G. S. Hotamisligil, "Inflammation and metabolic disorders, " Nature, vol. 444, no. 7121, pp. 860-867, 2006.
14. C. A. Curat, A. Miranville, C. Sengenes et al. , "From blood monocytes to adipose tissue-resident macrophages. Induction of diapedesis by human mature adipocytes, " Diabetes, vol. 53, no. 5, pp. 1285-1292, 2004.
15. E. D. Rosen and B. M. Spiegelman, "Adipocytes as regulators of energy balance and glucose homeostasis, " Nature, vol. 444, no. 7121, pp. 847-853, 2006.
16. G. S. Hotamisligil, N. S. Shargill, and B. M. Spiegelman, "Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance, " Science, vol. 259, no. 5091, pp. 87-91, 1993.
17. J. G. Neels and J. M. Olefsky, "Inflamed fat: what starts the fire?" The Journal of Clinical Investigation, vol. 116, no. 1, pp. 33-35, 2006.
18. N. Kamei, K. Tobe, R. Suzuki et al. , "Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance, " The Journal of Biological Chemistry, vol. 281, no. 36, pp. 26602-26614, 2006.
19. H. Kanda, S. Tateya, Y. Tamori et al. , "MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity, "The Journal of Clinical Investigation, vol. 116, no. 6, pp. 1494-1505, 2006.
20. A. Soukas, P. Cohen, N. D. Socci, and J. M. Friedman, "Leptinspecific patterns of gene expression in white adipose tissue, " Genes and Development, vol. 14, no. 8, pp. 963-980, 2000.
21. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr. , "Obesity is associated with macrophage accumulation in adipose tissue, " The Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796-1808, 2003.
22. R. Cancello, C. Henegar, N. Viguerie et al. , "Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue ofmorbidly obese subjects after surgery-induced weight loss, " Diabetes, vol. 54, no. 8, pp. 2277-2286, 2005.
23. A. W. Ferrante Jr. , "Obesity-induced inflammation: a metabolic dialogue in the language of inflammation, " Journal of Internal Medicine, vol. 262, no. 4, pp. 408-414, 2007.
24. C. N. Lumeng, J. L. Bodzin, and A. R. Saltiel, "Obesity induces a phenotypic switch in adipose tissue macrophage polarization, " The Journal of Clinical Investigation, vol. 117, no. 1, pp. 175-184, 2007.
25. S. Cinti, G. Mitchell, G. Barbatelli et al. , "Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, " Journal of Lipid Research, vol. 46, no. 11, pp. 2347-2355, 2005.
26. K. Sun, C. M. Kusminski, and P. E. Scherer, "Adipose tissue remodeling and obesity, " The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2094-2101, 2011.
27. V. Catalan, J. Gomez-Ambrosi, A. Rodriguez, and G. Fruhbeck, "Role of extracellular matrix remodelling in adipose tissue pathophysiology: relevance in the development of obesity, " Histology and Histopathology, vol. 27, no. 12, pp. 1515-1528, 2012.
28. P. Trayhurn, "Hypoxia and adipose tissue function and dysfunction in obesity, " Physiological Reviews, vol. 93, no. 1, pp. 1-21, 2013.
29. P. Trayhurn, B. Wang, and I. S. Wood, "Hypoxia and the endocrine and signalling role of white adipose tissue, " Archives of Physiology and Biochemistry, vol. 114, no. 4, pp. 267-276, 2008.
30. T. Khan, E. S. Muise, P. Iyengar et al. , "Metabolic dysregulation and adipose tissue fibrosis: role of collagen VI, " Molecular and Cellular Biology, vol. 29, no. 6, pp. 1575-1591, 2009.
31. J. M. Way, W. W. Harrington, K. K. Brown et al. , "Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues, " Endocrinology, vol. 142, no. 3, pp. 1269-1277, 2001.
32. S. Z. Josefowicz, L.-F. Lu, and A. Y. Rudensky, "Regulatory T cells: mechanisms of differentiation and function, " Annual Review of Immunology, vol. 30, pp. 531-564, 2012.
33. M. Feuerer, L. Herrero, D. Cipolletta et al. , "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affectmetabolic parameters, " Nature Medicine, vol. 15, no. 8, pp. 930-939, 2009.
34. P. A. Kern, M. Saghizadeh, J. M. Ong, R. J. Bosch, R. Deem, and R. B. Simsolo, "The expression of tumor necrosis factor in human adipose tissue: regulation by obesity, weight loss, and relationship to lipoprotein lipase, " The Journal of Clinical Investigation, vol. 95, no. 5, pp. 2111-2119, 1995.
35. E. J. Park, J. H. Lee, G.-Y. Yu et al. , "Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression, " Cell, vol. 140, no. 2, pp. 197-208, 2010.
36. H. Xu, K. T. Uysal, J. D. Becherer, P. Arner, and G. S. Hotamisligil, "Altered tumor necrosis factor-κ(TNF-α) processing in adipocytes and increased expression of transmembrane TNF-κin obesity, " Diabetes, vol. 51, no. 6, pp. 1876-1883, 2002.
37. K. T. Uysal, S. M. Wiesbrock, M. W. Marino, and G. S. Hotamisligil, "Protection from obesity-induced insulin resistance in mice lacking TNF-κfunction, " Nature, vol. 389, no. 6651, pp. 610-614, 1997.
38. G. Winkler, P. Lakatos, F. Salamon et al. , "Elevated serum TNF-κlevel as a link between endothelial dysfunctioNandinsulin resistance in normotensive obese patients, " Diabetic Medicine, vol. 16, no. 3, pp. 207-211, 1999.
39. P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan, "Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance, " American Journal of Physiology: Endocrinology and Metabolism, vol. 280, no. 5, pp. E745-E751, 2001.
40. F. Ofei, S. Hurel, J. Newkirk, M. Sopwith, and R. Taylor, "Effects of an engineered human anti-TNF-κantibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM, " Diabetes, vol. 45, no. 3, pp. 881-885, 1996.
41. N. Paquot, M. J. Castillo, P. J. Lefebvre, and A. J. Scheen, "No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients, " Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 3, pp. 1316-1319, 2000.
42. H. Tilg and A. R. Moschen, "Adipocytokines:mediators linking adipose tissue, inflammatioNandimmunity, " Nature Reviews Immunology, vol. 6, no. 10, pp. 772-783, 2006.
43. K. L. Donnelly, C. I. Smith, S. J. Schwarzenberg, J. Jessurun, M. D. Boldt, and E. J. Parks, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, "The Journal of Clinical Investigation, vol. 115, no. 5, pp. 1343-1351, 2005.
44. P. Flachs, M. Rossmeisl, M. Bryhn, and J. Kopecky, "Cellular and molecular effects of n-3 polyunsaturated fatty acids on adipose tissue biology and metabolism, " Clinical Science, vol. 116, no. 1, pp. 1-16, 2009.
45. S. E. McQuaid, L. Hodson, M. J. Neville et al. , "Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition?" Diabetes, vol. 60, no. 1, pp. 47-55, 2011.
46. K. A. Britton and C. S. Fox, "Ectopic fat depots and cardiovascular disease, " Circulation, vol. 124, no. 24, pp. e837-e841, 2011.
47. J. F. Caro, J. W. Kolaczynski, M. R. Nyce et al. , "Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance, " The Lancet, vol. 348, no. 9021, pp. 159-161, 1996.
48. R. Cancello, J. Tordjman, C. Poitou et al. , "Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity, " Diabetes, vol. 55, no. 6, pp. 1554-1561, 2006.
49. D. Patsouris, P.-P. Li, D. Thapar, J. Chapman, J. M. Olefsky, and J. G. Neels, "Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals, " Cell Metabolism, vol. 8, no. 4, pp. 301-309, 2008.
50. S. Fujisaka, I. Usui, A. Bukhari et al. , "Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice, " Diabetes, vol. 58, no. 11, pp. 2574-2582, 2009.
51. A. S. Rossi, Y. B. Lombardo, and A. G. Chicco, "Lipogenic enzyme activities and glucose uptake in fat tissue of dyslipemic, insulin-resistant rats: effects of fish oil, " Nutrition, vol. 26, no. 2, pp. 209-217, 2010.
52. M. J. Puglisi, A. H. Hasty, and V. Saraswathi, "The role of adipose tissue in mediating the beneficial effects of dietary fish oil, " The Journal of Nutritional Biochemistry, vol. 22, no. 2, pp. 101-108, 2011.
53. P. C. Calder, "Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?" British Journal of Clinical Pharmacology, vol. 75, no. 3, pp. 645-662, 2013.
54. P. M. Kris-Etherton, W. S. Harris, and L. J. Appel, "Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease, " Circulation, vol. 106, no. 21, pp. 2747-2757, 2002.
55. J. Delarue, C. LeFoll, C. Corporeau, and D. Lucas, "n-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?" ReproductionNutritionDevelopment, vol. 44, no. 3, pp. 289-299, 2004.
56. F. Belzung, T. Raclot, and R. Groscolas, "Fish oil n-3 fatty acids selectively limit the hypertrophy of abdominal fat depots in growing rats fed high-fat diets, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 264, no. 6, pp. R1111-R1118, 1993.
57. T. Raclot, R. Groscolas, D. Langin, and P. Ferre, "Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues, " Journal of Lipid Research, vol. 38, no. 10, pp. 1963-1972, 1997.
58. J. Ruzickova, M. Rossmeisl, T. Prazak et al. , "Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue, " Lipids, vol. 39, no. 12, pp. 1177-1185, 2004.
59. D. Y. Oh, S. Talukdar, E. J. Bae et al. , "GPR120 is anomega-3 fatty acid receptor mediating potent anti-inflammatory and insulinsensitizing effects, " Cell, vol. 142, no. 5, pp. 687-698, 2010.
60. C. Couet, J. Delarue, P. Ritz, J.-M. Antoine, and F. Lamisse, "Effect of dietary fish oil on body fat mass and basal fat oxidation in healthy adults, " International Journal of Obesity, vol. 21, no. 8, pp. 637-643, 1997.
61. T. A. Mori, D. Q. Bao, V. Burke, I. B. Puddey, G. F. Watts, and L. J. Beilin, "Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects, " The American Journal of Clinical Nutrition, vol. 70, no. 5, pp. 817-825, 1999.
62. J. D. Buckley and P. R. C. Howe, "Long-chain omega-3 polyunsaturated fatty acids may be beneficial for reducing obesity-a review, " Nutrients, vol. 2, no. 12, pp. 1212-1230, 2010.
63. D. E. Cintra, E. R. Ropelle, J. C. Moraes et al. , "Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity, " PLoS ONE, vol. 7, no. 1, Article ID e30571, 2012.
64. R. Buettner, K. G. Parhofer, M. Woenckhaus et al. , "Defining high-fat-diet rat models: metabolic and molecular effects of different fat types, " Journal of Molecular Endocrinology, vol. 36, no. 3, pp. 485-501, 2006.
65. A. P. Simopoulos, "The importance of the ratio of omega-6/omega-3 essential fatty acids, " Biomedicine and Pharmacotherapy, vol. 56, no. 8, pp. 365-379, 2002.
66. A. P. Simopoulos, "The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases, " Experimental Biology and Medicine, vol. 233, no. 6, pp. 674-688, 2008.
67. L. G. Cleland , M. J. James, M. A. Neumann, M. D. Angelo, and R. A. Gibson, "Linoleate inhibits EPA incorporation from dietary fish-oil supplements in human subjects, " The American Journal of Clinical Nutrition, vol. 55, no. 2, pp. 395-399, 1992.
68. M. J. James, L. G. Cleland , R. A. Gibson, and J. S. Hawkes, "Interaction between fish and vegetable oils in relation to rat leucocyte leukotriene production, " The Journal of Nutrition, vol. 121, no. 5, pp. 631-637, 1991.
69. P. Wortman, Y. Miyazaki, N. S. Kalupahana et al. , "n3 and n6 polyunsaturated fatty acids differentially modulate prostagland in E secretion but not markers of lipogenesis in adipocytes, " Nutrition and Metabolism, vol. 6, article 5, 2009.
70. L. M. Arterburn, E. B. Hall, and H. Oken, "Distribution, interconversion, and dose response of n-3 fatty acids in humans, "The American Journal of Clinical Nutrition, vol. 83, no. 6, pp. S1467-1476S, 2006.
71. J. T. Brenna, N. Salem Jr. , A. J. Sinclair, and S. C. Cunnane, "α-linolenic acid supplementation and conversion to n-3 longchain polyunsaturated fatty acids in humans, " Prostagland ins Leukotrienes and Essential FattyAcids, vol. 80, no. 2-3, pp. 85-91, 2009.
72. P. C. Calder, "Polyunsaturated fatty acids and inflammation, " Prostagland ins, Leukotrienes and Essential Fatty Acids, vol. 75, no. 3, pp. 197-202, 2006.
73. C. C. Tai and S. T. Ding, "N-3 polyunsaturated fatty acids regulate lipidmetabolism through several inflammation mediators: mechanisms and implications for obesity prevention, " The Journal of Nutritional Biochemistry, vol. 21, no. 5, pp. 357-363, 2010.
74. N. S. Kalupahana, K. J. Claycombe, and N. Moustaid-Moussa, "(n-3) Fatty acids alleviate adipose tissue inflammatioNandinsulin resistance: mechanistic insights, " Advances in Nutrition, vol. 2, no. 4, pp. 304-316, 2011.
75. M. J. James, R. A. Gibson, and L. G. Cleland , "Dietary polyunsaturated fatty acids and inflammatory mediator production, " The American Journal of ClinicalNutrition, vol. 71, no. 1, supplement, pp. 343S-348S, 2000.
76. T. H. Lee, R. L. Hoover, J. D. Williams et al. , "Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophiland monocyte leukotriene generation and neutrophil function, "The New England Journal ofMedicine, vol. 312, no. 19, pp. 1217-1224, 1985.
77. B. R. Lokesh and J. E. Kinsella, "Modulation of prostagland in synthesis in mouse peritoneal macrophages by enrichment of lipids with either eicosapentaenoic or docosahexaenoic acids in vitro, " Immunobiology, vol. 175, no. 5, pp. 406-419, 1987.
78. A. Arieland C. N. Serhan, "Resolvins and protectins in the termination program of acute inflammation, " Trends in Immunology, vol. 28, no. 4, pp. 176-183, 2007.
79. A. Gonzalez-Periz and J. Claria, "Resolution of adipose tissue inflammation, " TheScientificWorldJournal, vol. 10, pp. 832-856, 2010.
80. D. W. Gilroy, T. Lawrence, M. Perretti, and A. G. Rossi, "Inflammatory resolution: new opportunities for drug discovery, " Nature Reviews Drug Discovery, vol. 3, no. 5, pp. 401-416, 2004.
81. J. M. Schwab, N. Chiang, M. Arita, and C. N. Serhan, "Resolvin E1 and protectin D1 activate inflammation-resolution programmes, " Nature, vol. 447, no. 7146, pp. 869-874, 2007.
82. E. Titos, B. Rius, A. Gonzalez-Periz et al. , "Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype, "The Journal of Immunology, vol. 187, no. 10, pp. 5408-5418, 2011.
83. G. E. Caughey, E. Mantzioris, R. A. Gibson, L. G. Cleland , and M. J. James, "The effect on human tumor necrosis factor κ and interleukin 1β production of diets enriched in n-3 fatty acids from vegetable oil or fish oil, " The American Journal of Clinical Nutrition, vol. 63, no. 1, pp. 116-122, 1996.
84. S. N. Meydani, S. Endres, M. M. Woods et al. , "Oral (n-3) fatty acid supplementation suppresses cytokine production and lymphocyte proliferation: comparison between young and older women, " Journal of Nutrition, vol. 121, no. 4, pp. 547-555, 1991.
85. S. Endres, R. Ghorbani, V. E. Kelley et al. , "The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells, " The New England Journal of Medicine, vol. 320, no. 5, pp. 265-271, 1989.
86. T. E. Novak, T. A. Babcock, D. H. Jho, W. S. Helton, and N. J. Espat, "NF-κB inhibition by ω-3 fatty acids modulates LPSstimulated macrophage TNF-α-transcription, " The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 284, no. 1, pp. L84-L89, 2003.
87. Y. Zhao, S. Joshi-Barve, S. Barve, and L. H. Chen, "Eicosapentaenoic acid prevents LPS-induced TNF-κexpression by preventing NF-κB activation, " Journal of the American College of Nutrition, vol. 23, no. 1, pp. 71-78, 2004.
88. G. Zhao, T. D. Etherton, K. R. Martin et al. , "Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells, " Biochemicaland Biophysical Research Communications, vol. 336, no. 3, pp. 909-917, 2005.
89. M. Zeyda, D. Farmer, J. Todoric et al. , "Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production, " International Journal of Obesity, vol. 31, no. 9, pp. 1420-1428, 2007.
90. J. Todoric, M. Loffler, J. Huber et al. , "Adipose tissue inflammation induced by high-fat diet in obese diabetic mice is prevented by n-3 polyunsaturated fatty acids, " Diabetologia, vol. 49, no. 9, pp. 2109-2119, 2006.
91. D. A. Raptis, P. Limani, J. H. Jang et al. , "GPR120 on Kupffer cells mediates hepatoprotective effects of ω3-fatty acids, " Journal of Hepatology, vol. 60, no. 3, pp. 625-632, 2014.
92. H.-K. Kim, M. Della-Fera, J. Lin, and C. A. Baile, "Docosahexaenoic acid inhibits adipocyte differentiatioNandinduces apoptosis in 3T3-L1 preadipocytes, " The Journal of Nutrition, vol. 136, no. 12, pp. 2965-2969, 2006.
93. P. Flachs, O. Horakova, P. Brauner et al. , "Polyunsaturated fatty acids of marine origin upregulatemitochondrial biogenesis and induce β-oxidation in white fat, " Diabetologia, vol. 48, no. 11, pp. 2365-2375, 2005.
94. P. Janovska, P. Flachs, L. Kazdova, and J. Kopecky, "Anti-obesity effect of n-3 polyunsaturated fatty acids in mice fed high-fat diet is independent of cold-induced thermogenesis, " Physiological Research, vol. 62, no. 2, pp. 153-161, 2013.
95. J. Huber, M. Loffler, M. Bilban et al. , "Prevention of high-fat diet-induced adipose tissue remodeling in obese diabetic mice by n-3 polyunsaturated fatty acids, " International Journal of Obesity, vol. 31, no. 6, pp. 1004-1013, 2007.
96. A. Okuno, H. Tamemoto, K. Tobe et al. , "Troglitazone increases the number of small adipocytes without the change of white adipose tissuemass in obese Zucker rats, "The Journal of Clinical Investigation, vol. 101, no. 6, pp. 1354-1361, 1998.
97. N. S. Kalupahana, K. Claycombe, S. J. Newman et al. , "Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation, " The Journal of Nutrition, vol. 140, no. 11, pp. 1915-1922, 2010.
98. A. S. Rossi, Y. B. Lombardo, J.-M. Lacorte et al. , "Dietary fish oil positively regulates plasma leptin and adiponectin levels in sucrose-fed, insulin-resistant rats, " American Journal of Physiology-Regulatory Integrative and Comparative Physiology, vol. 289, no. 2, pp. R486-R494, 2005.
99. C. Fan, X. Liu, W. Shen, R. J. Deckelbaum, and K. Qi, "The regulation of leptin, leptin receptor and pro-opiomelanocortin expression by N-3 PUFAs in diet-induced obese mice is not related to the methylation of their promoters, " Nutrition and Metabolism, vol. 8, article 31, 2011.
100. P. Flachs, V. Mohamed-Ali, O. Horakova et al. , "Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet, " Diabetologia, vol. 49, no. 2, pp. 394-397, 2006.
101. N. Perez-Echarri, P. Perez-Matute, B. Marcos-Gomez, J. A. Martinez, and M. J. Moreno-Aliaga, "Effects of eicosapentaenoic acid ethyl ester on visfatin and apelin in lean and overweight (cafeteria diet-fed) rats, " British Journal of Nutrition, vol. 101, no. 7, pp. 1059-1067, 2009.
102. M. Muurling, R. P. Mensink, H. Pijl, J. A. Romijn, L. M. Havekes, and P. J. Voshol, "A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-κprotein concentration inApoE-3∗ leiden mice, " Journal ofNutrition, vol. 133, no. 11, pp. 3350-3355, 2003.
103. N. Perez-Echarri, P. Perez-Matute, B. Marcos-Gomez et al. , "Differential inflammatory status in rats susceptible or resistant to diet-induced obesity: effects of EPA ethyl ester treatment, " European Journal of Nutrition, vol. 47, no. 7, pp. 380-386, 2008.
104. J. Luo, S. W. Rizkalla, J. Boillot et al. , "Dietary (n-3) polyunsaturated fatty acids improve adipocyte insulin action and glucose metabolism in insulin-resistant rats: relation to membrane fatty acids, " The Journal of Nutrition, vol. 126, no. 8, pp. 1951-1958, 1996.
105. M. Fickova, P. Hubert, G. Cremel, and C. Leray, "Dietary (n-3) and (n-6) polyunsaturated fatty acids rapidly modify fatty acid compositioNandinsulin effects in rat adipocytes, " The Journal of Nutrition, vol. 128, no. 3, pp. 512-519, 1998.
106. G. R. Herzberg and C. Skinner, "Differential accumulation and release of long-chain n-3 fatty acids from liver, muscle, and adipose tissue triacylglycerols, " Canadian Journal of Physiology and Pharmacology, vol. 75, no. 8, pp. 945-951, 1997.
107. J. D. Krebs, L. M. Browning, N. K. McLean et al. , "Additive benefits of long-chain n-3 polyunsaturated fatty acids and weight-loss in the management of cardiovascular disease risk in overweight hyperinsulinaemic women, " International Journal of Obesity, vol. 30, no. 10, pp. 1535-1544, 2006.
108. Y. B. Lombardo, G. Hein, and A. Chicco, "Metabolic syndrome: effects of n-3 PUFAs on a model of dyslipidemia, insulin resistance and adiposity, " Lipids, vol. 42, no. 5, pp. 427-437, 2007.
109. A. Haug and A. T. Hostmark, "Lipoprotein lipases, lipoproteins and tissue lipids in rats fed fish oil or coconut oil, " Journal of Nutrition, vol. 117, no. 6, pp. 1011-1017, 1987.
110. T. Yamauchi, J. Kamon, Y. Minokoshi et al. , "Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, " Nature Medicine, vol. 8, no. 11, pp. 1288-1295, 2002.
111. Y. Sharabi, M. Oron-Herman, Y. Kamari et al. , "Effect of PPAR-γ agonist on adiponectin levels in the metabolic syndrome: lessons fromthe high fructose fed ratmodel, " American Journal of Hypertension, vol. 20, no. 2, pp. 206-210, 2007.
112. M. Iwabu, T. Yamauchi, M. Okada-Iwabu et al. , "Adiponectin and AdipoR1 regulate PGC-1κ and mitochondria by Ca2+ and AMPK/SIRT1, " Nature, vol. 464, no. 7293, pp. 1313-1319, 2010.
113. X. Zhang, G. Zhang, H. Zhang, M. Karin, H. Bai, and D. Cai, "Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity, " Cell, vol. 135, no. 1, pp. 61-73, 2008.
114. M. Milanski, G. Degasperi, A. Coope et al. , "Saturatedfatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity, "TheJournal of Neuroscience, vol. 29, no. 2, pp. 359-370, 2009.
115. L. A. Moraes, L. Piqueras, and D. Bishop-Bailey, "Peroxisome proliferator-activated receptors and inflammation, " Pharmacology and Therapeutics, vol. 110, no. 3, pp. 371-385, 2006.
116. F. Huang, H. Wei, H. Luo, S. Jiang, and J. Peng, "EPAinhibits the inhibitor ofκbα(IκBα)/NF-κB/muscle RING finger 1 pathway in C2C12 myotubes in a PPARγ-dependent manner, " British Journal of Nutrition, vol. 105, no. 3, pp. 348-356, 2011.
117. M. Ricote, A. C. Li, T. M. Willson, C. J. Kelly, and C. K. Glass, "The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation, " Nature, vol. 391, no. 6662, pp. 79-82, 1998.
118. J. Zuniga, M. Cancino, F. Medina et al. , "N-3 PUFA supplementation triggers PPAR-κactivation and PPAR-α/NF-κB interaction: anti-inflammatory implications in liver ischemiareperfusion injury, " PLoS ONE, vol. 6, no. 12, Article IDe28502, 2011.
119. J. Kopecky, M. Rossmeisl, P. Flachs et al. , "N-3 PUFA: bioavailability and modulation of adipose tissue function, " Proceedings of the Nutrition Society, vol. 68, no. 4, pp. 361-369, 2009.
120. T. Obata, T. Nagakura, T. Masaki, K. Maekawa, and K. Yamashita, "Eicosapentaenoic acid inhibits prostagland in D2 generation by inhibiting cyclo-oxygenase-2 in cultured human mast cells, " Clinical and Experimental Allergy, vol. 29, no. 8, pp. 1129-1135, 1999.
121. P. Yaqoob and S. R. Shaikh, "The nutritionaland clinical significance of lipid rafts, " Current Opinion in Clinical Nutrition and Metabolic Care, vol. 13, no. 2, pp. 156-166, 2010.
122. T. M. Stulnig, J. Huber, N. Leitinger et al. , "Polyunsaturated eicosapentaenoic acid displaces proteins from membrane rafts by altering raft lipid composition, " Journal of Biological Chemistry, vol. 276, no. 40, pp. 37335-37340, 2001.
123. Q. Li, M. Wang, L. Tan et al. , "Docosahexaenoic acid changes lipid compositioNandinterleukin-2 receptor signaling in membrane rafts, " The Journal of Lipid Research, vol. 46, no. 9, pp. 1904-1913, 2005.
124. L. Villacorta, L. Chang, S. R. Salvatore et al. , "Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts, " Cardiovascular Research, vol. 98, no. 1, pp. 116-124, 2013.
125. P. R. Devchand , H. Keller, J. M. Peters, M. Vazquez, F. J. Gonzalez, and W. Wahli, "The PPARα-leukotriene B4 pathway to inflammation control, " Nature, vol. 384, no. 6604, pp. 39-43, 1996.
126. R. Kapadia, J.-H. Yi, and R. Vemuganti, "Mechanisms of antiinflammatory and neuroprotective actions of PPAR-gamma agonists, " Frontiers in Bioscience, vol. 13, no. 5, pp. 1813-1826, 2008.
127. A. Chawla, E. J. Schwarz, D. D. Dimaculangan, and M. A. Lazar, "Peroxisome proliferator-activated receptor (PPAR)γ: adiposepredominant expressioNandinduction early in adipocyte differentiation, " Endocrinology, vol. 135, no. 2, pp. 798-800, 1994.
128. B. M. Spiegelman, "PPAR-γ: adipogenic regulator and thiazolidinedione receptor, " Diabetes, vol. 47, no. 4, pp. 507-514, 1998.
129. P. Tontonoz, E. Hu, and B. M. Spiegelman, "Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor, " Cell, vol. 79, no. 7, pp. 1147-1156, 1994.
130. X. Yang and U. Smith, "Adipose tissue distribution and risk of metabolic disease: does thiazolidinedione-induced adipose tissue redistribution provide a clue to the answer?" Diabetologia, vol. 50, no. 6, pp. 1127-1139, 2007.
131. L. Tao, Y. Wang, E. Gao et al. , "Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction, " Circulation Research, vol. 106, no. 2, pp. 409-417, 2010.
132. J. M. Tishinsky, D. W. L. Ma, and L. E. Robinson, "Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes, " Obesity, vol. 19, no. 2, pp. 262-268, 2011.
133. S. Neschen, K. Morino, J. C. Rossbacher et al. , "Fish oil regulates adiponectin secretion by a peroxisome proliferator-activated receptor-γ-dependent mechanism in mice, " Diabetes, vol. 55, no. 4, pp. 924-928, 2006.
134. R. Stienstra, C. Duval, S. Keshtkar, J. van der Laak, S. Kersten, and M. Muller, "Peroxisome proliferator-activated receptor γ activation promotes infiltration of alternatively activated macrophages into adipose tissue, " The Journal of Biological Chemistry, vol. 283, no. 33, pp. 22620-22627, 2008.
135. J. I. Odegaard, R. R. Ricardo-Gonzalez, M. H. Goforth et al. , "Macrophage-specific PPARγ controls alternative activatioNandimproves insulin resistance, " Nature, vol. 447, no. 7148, pp. 1116-1120, 2007.
136. A. L. Hevener, J. M. Olefsky, D. Reichart et al. , "Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones, " The Journal of Clinical Investigation, vol. 117, no. 6, pp. 1658-1669, 2007.
137. C. Jiang, A. T. Ting, and B. Seed, "PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, " Nature, vol. 391, no. 6662, pp. 82-86, 1998.
138. D. Cipolletta, M. Feuerer, A. Li et al. , "PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells, " Nature, vol. 486, no. 7404, pp. 549-553, 2012.
139. G. Krey, O. Braissant, F. L Horset et al. , "Fatty acids, eicosanoids, and hypolipidemic agents identified as lig and s of peroxisome proliferator-activated receptors by coactivator-dependent receptor lig and assay, " Molecular Endocrinology, vol. 11, no. 6, pp. 779-791, 1997.
140. E. Oliver, F. McGillicuddy, C. Phillips, S. Toomey, and H. M. Roche, "The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA, " Proceedings of the Nutrition Society, vol. 69, no. 2, pp. 232-243, 2010.
141. R. G. Baker, M. S. Hayden, and S. Ghosh, "NF-κB, inflammation, and metabolic disease, " Cell Metabolism, vol. 13, no. 1, pp. 11-22, 2011.
142. D. Cai, M. Yuan, D. F. Frantz et al. , "Localand systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB, " Nature Medicine, vol. 11, no. 2, pp. 183-190, 2005.
143. M. C. Arkan, A. L. Hevener, F. R. Greten et al. , "IKK-β links inflammation to obesity-induced insulin resistance, " Nature Medicine, vol. 11, no. 2, pp. 191-198, 2005.
144. F. R. Greten, L. Eckmann, T. F. Greten et al. , "IKKβ links inflammation and tumorigenesis in a mouse model of colitisassociated cancer, " Cell, vol. 118, no. 3, pp. 285-296, 2004.
145. Y. Wang, Q.-W. Lin, P.-P. Zheng, J.-S. Zhang, and F.-R. Huang, "DHA inhibits protein degradation more efficiently than EPA by regulating the PPARγ /NFκB pathway in C2C12 myotubes, " BioMed Research International, vol. 2013, Article ID 318981, 9 pages, 2013.
146. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, "Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4, " The Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683-16689, 2001.
147. A. Hirasawa, K. Tsumaya, T. Awaji et al. , "Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120, " Nature Medicine, vol. 11, no. 1, pp. 90-94, 2005.
148. A. Ichimura, A. Hirasawa, O. Poulain-Godefroy et al. , "Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human, " Nature, vol. 483, no. 7389, pp. 350-354, 2012.
149. J. C. Jimenez-Chillaron, R. Diaz, D. Martinez et al. , "The role of nutrition on epigeneticmodifications and their implications on health, " Biochimie, vol. 94, no. 11, pp. 2242-2263, 2012.
150. N. A. Youngson and M. J. Morris, "What obesity research tells us about epigenetic mechanisms, " Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 368, no. 1609, 2013.
151. V. Ceccarelli, S. Racanicchi, M. P. Martelli et al. , "Eicosapentaenoic acid demethylates a single CpG that mediates expression of tumor suppressor CCAAT/enhancer-binding protein δ in U937 leukemia cells, "The Journal of Biological Chemistry, vol. 286, no. 31, pp. 27092-27102, 2011.
152. V. Primeau, L. Coderre, A. D. Karelis et al. , "Characterizing the profile of obese patients who are metabolically healthy, " International Journal of Obesity, vol. 35, no. 7, pp. 971-981, 2011.